Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Siena

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
Haematologica|March 1, 1991
Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patientsF Ravagnani, S Siena, M Bregni, et al.
Cancer Research|January 4, 1998
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursorsR Mortarini, A Anichini, M Di Nicola, et al.
Haematologica|April 6, 1999
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemiaS Siena, G Sammarelli, M G Grimoldi, et al.
Bone Marrow Transplantation|August 1, 1995
Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilizationC Tarella, D Caracciolo, P Gavarotti, et al.
Bone Marrow Transplantation|September 1, 1996
Benefits of blood cell transplant cryopreservation with oxypolygelatine (Gelifundol) plasma substituteM Di Nicola, S Siena, M Bregni, et al.
Stem Cells (Dayton, Ohio)|July 1, 1993
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s)S Siena, M Bregni, L Bonsi, et al.
Bone Marrow Transplantation|August 28, 2003
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999P Pedrazzoli, P Ferrante, A Kulekci, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1990
Total body irradiation and high-dose melphalan with bone marrow transplantation at Istituto Nazionale Tumori, Milan, ItalyL Gandola, F Lombardi, S Siena, et al.
The Tokai Journal of Experimental and Clinical Medicine|June 1, 1985
Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletionR J O'Reilly, N Collins, R Dinsmore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experienceG Bonadonna, A Santoro, A M Gianni, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Haematologica|March 1, 1991
Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patientsF Ravagnani, S Siena, M Bregni, et al.
Cancer Research|January 4, 1998
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursorsR Mortarini, A Anichini, M Di Nicola, et al.
Haematologica|April 6, 1999
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemiaS Siena, G Sammarelli, M G Grimoldi, et al.
Bone Marrow Transplantation|August 1, 1995
Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilizationC Tarella, D Caracciolo, P Gavarotti, et al.
Bone Marrow Transplantation|September 1, 1996
Benefits of blood cell transplant cryopreservation with oxypolygelatine (Gelifundol) plasma substituteM Di Nicola, S Siena, M Bregni, et al.
Stem Cells (Dayton, Ohio)|July 1, 1993
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s)S Siena, M Bregni, L Bonsi, et al.
Bone Marrow Transplantation|August 28, 2003
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999P Pedrazzoli, P Ferrante, A Kulekci, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1990
Total body irradiation and high-dose melphalan with bone marrow transplantation at Istituto Nazionale Tumori, Milan, ItalyL Gandola, F Lombardi, S Siena, et al.
The Tokai Journal of Experimental and Clinical Medicine|June 1, 1985
Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletionR J O'Reilly, N Collins, R Dinsmore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experienceG Bonadonna, A Santoro, A M Gianni, et al.
Pageof 17